Clinical Trials Sponsored by HemoSonics LLC

Total 10738 results

HemoSonics LLC

Completed

Coagulation Changes Associated With COVID-19 Infection

Coagulation Disorder | COVID | Disseminated Intravascular Coagulation

United States
HemoSonics LLC

Completed

QStat Pilot Reference Range Study

Coagulation Disorder

United States
HemoSonics LLC

Completed

Reference Range Study for the Quantra Analyzer With the Quantra Surgical Cartridge

Coagulation

United States
HemoSonics LLC

Terminated

QPlus Pediatric Reference Interval

Healthy | Pediatric ALL

United States
HemoSonics LLC

Completed

Quantra QPlus Sample Type Comparison

Coagulation Defect; Bleeding

United States
HemoSonics LLC

Completed

QStat in Liver Transplant

Blood Loss, Surgical

United States
HemoSonics LLC

Completed

Evaluation of the Quantra System in a Surgical Oncological Population

Blood Loss, Surgical

United States
HemoSonics LLC

Completed

Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge in Trauma

Trauma | Blood Loss Massive

United States
HemoSonics LLC

Completed

Evaluation of the Clinical Performance of the Quantra System With the Quantra Surgical Cartridge

Blood Loss, Surgical

United States
HemoSonics LLC

Enrolling by invitation

Reference Range Study for the Quantra System With the QStat Cartridge in Obstetric Patients

Coagulation | Obstetric Hemostasis

United States
HemoSonics LLC

Completed

Evaluation of the Quantra QStat System in Obstetric Patients

Post Operative Hemorrhage | Blood Loss Massive

United States
HemoSonics LLC

Completed

Quantra QStat Sample Type Comparison

Coagulation Defect; Bleeding

United States
HemoSonics LLC

Enrolling by invitation

QStat Cartridge in Obstetric Patients

Post Partum Hemorrhage | Blood Loss Massive

United States
HemoSonics LLC

Completed

Quantra QStat in Trauma and Liver Transplant

Hemorrhage | Trauma | Liver Transplant

United States
HemoSonics LLC

Completed

Use of the Quantra QPlus Sytem in Cardiac Surgery

Cardiovascular Diseases

United States
HemoSonics LLC

Completed

QStat in Trauma and Obstetric Hemorrhage

Trauma | Post Partum Hemorrhage | Blood Loss Massive

United States
HemoSonics LLC

Completed

Reference Range Study for the Quantra QStat System

Coagulation Disorder

United States
HemoSonics LLC

Completed

Pre-surgical Evaluation for the Quantra System in Adult Patients Undergoing Cardiac Surgery

Blood Loss, Surgical

United States
HemoSonics LLC

Completed

HemoSonics - UTMB Cardiac Surgery Study

Blood Loss, Surgical

United States
HemoSonics LLC

Completed

Evaluation of the Clinical Performance of the Quantra System With the QStat Cartridge

Trauma | Hemorrhage, Postpartum | Blood Loss Massive

United States
University of Virginia
HemoSonics LLC

Completed

HemoSonics-UVA HemoSonics-UVA Cardiac Surgery Clinical Study Protocol

Coronary Artery Disease

United States
HemoSonics LLC
University Hospital, Lille

Completed

Quantra® System With the QStat® Cartridge in Trauma

Trauma | Coagulation Defect; Bleeding

France
HemoSonics LLC
University of Virginia

Completed

Quantra Determination of Coagulation Parameters in Arterial and Venous Blood

Cardiac Surgery

United States
University of Virginia
HemoSonics LLC

Completed

HemoSonics-UVA Spinal Surgery

Deformity of Spine

United States
Virginia Commonwealth University
HemoSonics LLC

Completed

Hemosonics- VCU Cardiac Surgery Clinical Study

Cardiopulmonary Bypass

United States
HemoSonics LLC
IRCCS Policlinico S. Donato

Completed

Comparison of Two Point-of-care Devices for Viscoelastic Hemostasis Assays

Coagulation Disorder

Italy
HemoSonics LLC
University of California, Irvine

Completed

Exploratory Assessment of the Quantra® System in Adult ECMO Patients

Thrombosis | Blood Loss | Extracorporeal Circulation; Complications

United States
University of Maryland, Baltimore
HemoSonics LLC

Completed

Evaluation of Novel Point of Care Coagulation System in Pregnant Women (CCPW)

Hemorrhage | Coagulation Delay

United States
Johann Wolfgang Goethe University Hospital
HemoSonics LLC

Terminated

Validation of a Quantra Supported Hemotherapy Algorithm in Cardiac Surgery

Hemorrhage | Bleeding

Germany
Cambridge University Hospitals NHS Foundation Trust
HemoSonics LLC

Withdrawn

Clinical Evaluation of the Hemosonics Quantra® Coagulation Monitor in Liver and Multivisceral Transplantation

Liver Transplantation | Coagulopathy
Arthritis Northwest PLLC
Epigenesys LLC

Unknown

Identification of Epigenetic Biomarkers for Early Detection of Rheumatic Disease

Arthritis, Rheumatoid

United States
Angle plc
MidLantic Urology, LLC

Terminated

Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System (CHARTER)

Prostate Cancer | Castration-resistant Prostate Cancer | Biochemically Recurrent Prostate Carcinoma | High Risk Prostate Carcinoma

United States
Synochi, LLC
LAC+USC Medical Center

Not yet recruiting

Prospective Placebo-controlled Study of Synochi Scar Spray

Burns Multiple
LLS PedAL Initiative, LLC
Kura Oncology

Not yet recruiting

Ziftomenib in Combination With Chemotherapy for Children With Relapsed/Refractory Acute Leukemia

Relapsed/Refractory KMT2A-r Acute Leukemia | Relapsed/Refractory NUP98-r Acute Leukemia | Relapsed/Refractory NPM1-m Acute Leukemia
Derm Research, PLLC
WFH MEDICAL, LLC

Completed

Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel

Acne Vulgaris

United States
Verily Life Sciences LLC
The Emmes Company, LLC; Optos, PLC; Google LLC.; Nikon Corporation

Completed

ARDA Software for the Detection of mtmDR

Diabetic Retinopathy

United States
MedRegen LLC
Johns Hopkins University; ICON plc

Recruiting

MRG-001 as an Immunoregulatory and Regenerative Therapy for COVID-19 Patients

COVID-19 | ARDS, Human | Regeneration | Stem Cells

United States
Redx Pharma Plc
Merck Sharp & Dohme LLC

Completed

A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2) (KEYNOTE-E86)

Advanced Solid Tumours

United Kingdom, Australia
4D pharma plc
Merck Sharp & Dohme LLC

Terminated

Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors

Melanoma | Renal Cell Carcinoma | Solid Tumor | Non Small Cell Lung Cancer | Bladder Cancer | Oncology

United States
IVFarma LLC
BridgePharm LLC; GlobalPharma LLC

Completed

Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment

Infertility, Female

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Not yet recruiting

Bioequivalence Study of Two Formulations of Etoricoxib Tablets 120 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Not yet recruiting

Bioequivalence Study of Two Formulations of Rivaroxaban Tablets 20 mg in Healthy Male Volunteers Under Fed Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Two Formulations of Atorvastatin Film-coated Tablets 40 mg in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Two Formulations of Clopidogrel Film-coated Tablets 75 mg in Healthy Male Subjects Under Fasting Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Clavamox, Film-coated Tablets, 875 mg + 125 mg Pharmtechnology LLC, Belarus), and Augmentin®, Film-coated Tablets, 875 mg + 125 mg (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Clavamox, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (Pharmtechnology LLC, Belarus), and Augmentin®, Powder for Oral Suspension, 400 mg + 57 mg / 5 ml (GlaxoSmithKline Trading CJSC, Russia), in Healthy Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Not yet recruiting

Bioequivalence Study of Two Formulations of Sildenafil Tablet 100 mg in Healthy Male Volunteers Under Fasting Conditions

Bioequivalence

Russian Federation
IVFarma LLC
NADIM LLC

Completed

The Safety and Pharmacokinetics of Primapur and Gonal-f

Pharmacokinetics | Absorption | Area Under Curve

Russian Federation
Pharmtechnology LLC
ClinPharmInvest, LLC

Completed

Bioequivalence Study of Montelukast, 5 mg Chewable Tablets (Pharmtechnology LLC, Belarus), and Singulair®, 5 mg Chewable Tablets (Merck Sharp & Dohme B.V., the Netherlands), in Healthy Volunteers Under Fasting Conditions

Healthy Adults

Russian Federation
Immunitor LLC
Ekomed LLC

Unknown

Open Label Immunotherapy of Endometriosis

Endometriosis

Mongolia

Clinical Trials Sponsored by HemoSonics LLC

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Morocco

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations